PFGIA
VKTX icon

Patriot Financial Group Insurance Agency’s Viking Therapeutics VKTX Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-75
Closed -$1K – 1856
2020
Q2 		$1K Hold
75
– – ﹤0.01% 1598
2020
Q1 		$0 Hold
75
– – ﹤0.01% 1755
2019
Q4 		$1K Hold
75
– – ﹤0.01% 1270
2019
Q3 		$1K Hold
75
– – ﹤0.01% 1249
2019
Q2 		$1K Hold
75
– – ﹤0.01% 1356
2019
Q1 		$1K Hold
75
– – ﹤0.01% 1183
2018
Q4 		$1K Buy
+75
New +$897 ﹤0.01% 951

Other funds holding VKTX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Patriot Financial Group Insurance Agency's VKTX Position: Q3 2020 in Review

Patriot Financial Group Insurance Agency sold out of Viking Therapeutics (VKTX) in Q3 2020, closing a stake of 75 shares — an estimated $1K sold.

Patriot Financial Group Insurance Agency first reported a position in VKTX in Q4 2018 and held it in 7 quarters. The position peaked at $1K in Q2 2020. 140 funds tracked by Wall St. Rank hold VKTX as of Q3 2020.

  • Patriot Financial Group Insurance Agency reported no remaining Viking Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 75 Viking Therapeutics shares in Q3 2020, an estimated $1K.
  • Patriot Financial Group Insurance Agency first reported a position in Viking Therapeutics in Q4 2018 and held it in 7 quarters.
  • Patriot Financial Group Insurance Agency's Viking Therapeutics position peaked at $1K in Q2 2020.
  • 140 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2020.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2020, filed 21 Oct 2020.